ACM
EWTX icon

Aquatic Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Aquatic Capital Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+36,918
New +$1.27M 0.05% 446
2025
Q3 		– Sell
-27,042
Closed -$355K – 1474
2025
Q2 		$355K Buy
+27,042
New +$390K 0.01% 903
2025
Q1 		– Sell
-2,894
Closed -$77.3K – 1357
2024
Q4 		$77.3K Buy
+2,894
New +$92.1K ﹤0.01% 1111

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aquatic Capital Management's EWTX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 36,918 shares worth $1.5M. The stake represents 0.05% of the portfolio and ranks #446 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in EWTX as recently as Q2 2025.

Aquatic Capital Management first reported a position in EWTX in Q4 2024 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Aquatic Capital Management held 36,918 shares of Edgewise Therapeutics worth $1.5M as of Q2 2026.
  • Edgewise Therapeutics was a new Aquatic Capital Management position in Q2 2026.
  • Edgewise Therapeutics made up 0.05% of Aquatic Capital Management's portfolio in Q2 2026, its #446 holding.
  • Aquatic Capital Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.